Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria.
IgG and IgG3 antibodies to merozoite surface protein-2 (MSP-2) of Plasmodium falciparum have been associated with protection from clinical malaria in independent studies. We determined whether this protection was allele-specific by testing whether children who developed clinical malaria lacked IgG/IgG3 antibodies specific to the dominant msp2 parasite genotypes detected during clinical episodes. We analysed pre-existing IgG and IgG1/IgG3 antibodies to antigens representing the major dimorphic types of MSP-2 by ELISA. We used quantitative real-time PCR to determine the dominant msp2 alleles in parasites detected in clinical episodes. Over half (55%, 80/146) of infections contained both allelic types. Single or dominant IC1- and FC27-like alleles were detected in 46% and 42% of infections respectively, and both types were equally dominant in 12%. High levels of IgG/IgG3 antibodies to the FC27-like antigen were not significantly associated with a lower likelihood of clinical episodes caused by parasites bearing FC27-like compared to IC1-like alleles, and vice versa for IgG/IgG3 antibodies to the IC1-like antigen. These findings were supported by competition ELISAs which demonstrated the presence of IgG antibodies to allele-specific epitopes within both antigens. Thus, even for this well-studied antigen, the importance of an allele-specific component of naturally acquired protective immunity to malaria remains to be confirmed.
Osier
F H A
FH
KEMRI-Centre for Geographic Medicine Research, Coast, Kilifi, Kenya. fosier@kilifi.kemri-wellcome.org
Murungi
L M
LM
Fegan
G
G
Tuju
J
J
Tetteh
K K
KK
Bull
P C
PC
Conway
D J
DJ
Marsh
K
K
D000483:Alleles; D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood*; D000953:Antigens, Protozoan / Q000235:genetics / Q000276:immunology*; D002675:Child, Preschool; D016054:DNA, Protozoan / Q000235:genetics; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007223:Infant; D016778:Malaria, Falciparum / Q000276:immunology / Q000517:prevention & control*; D010963:Plasmodium falciparum / Q000276:immunology*; D016133:Polymerase Chain Reaction; D015800:Protozoan Proteins / Q000235:genetics / Q000276:immunology*
D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D016054:DNA, Protozoan; D007074:Immunoglobulin G; D015800:Protozoan Proteins; C065974:merozoite surface protein 2, Plasmodium
Am J Trop Med Hyg. 1996 Jun;54(6):632-43
8686784
Am J Trop Med Hyg. 1998 Apr;58(4):406-13
9574783
Parasitology. 2001 Aug;123(Pt 2):113-23
11510676
Infect Immun. 1997 Nov;65(11):4419-23
9353014
Adv Parasitol. 2008;66:1-46
18486688
Br Med Bull. 1951;8(1):51-5
14944815
Biopolymers. 2007 Sep;87(1):12-22
17516503
Mol Microbiol. 2003 Jul;49(1):179-91
12823820
Infect Immun. 2009 Mar;77(3):1165-74
19139189
Am J Trop Med Hyg. 1996 Jan;54(1):18-26
8651363
Malar J. 2007 Jun 28;6:82
17598897
PLoS Biol. 2003 Oct;1(1):E5
12929205
Clin Exp Immunol. 2002 Aug;129(2):326-31
12165090
Mol Biochem Parasitol. 2003 Oct;131(2):83-91
14511807
Infect Immun. 2001 Feb;69(2):959-67
11159991
Parasitol Today. 1992 Nov;8(11):381-3
15463547
Infect Immun. 2008 Apr;76(4):1748-55
18212081
Parasite Immunol. 2003 Nov-Dec;25(11-12):531-43
15053774
Infect Immun. 1996 Aug;64(8):3310-7
8757869
Infect Immun. 2008 May;76(5):2240-8
18316390
Parasite Immunol. 2003 Jun;25(6):307-12
14507328
Parasitology. 2002;125 Suppl:S3-16
12622324
Infect Immun. 2003 Jun;71(6):3485-95
12761133
Vaccine. 2006 May 8;24(19):4233-46
16111789
Am J Trop Med Hyg. 2007 Jun;76(6):1084-91
17556615
Acta Trop. 2002 Nov;84(2):83-92
12429425
Parasite Immunol. 2007 Aug;29(8):387-94
17650180
Am J Trop Med Hyg. 1997 May;56(5):538-47
9180605
J Infect Dis. 2002 Mar 15;185(6):820-7
11920300
Parasitology. 2002 Jun;124(Pt 6):569-81
12118712
Clin Diagn Lab Immunol. 2003 Sep;10(5):973-6
12965937